TELEDYNE TECHNOLOGIES INC Q1 FY2025 earnings call

Management Statement and Operational Highlights

• Quarter Performance: Achieved records in first quarter total sales (+7.4%), organic growth in all segments, non-GAAP and GAAP earnings per share, and operating margin. Closed Qioptiq carve-out acquisition. Orders exceeded sales for sixth consecutive quarter.
• Supply Chain and Tariffs: Little low-cost country manufacturing, net exporter. Imported relatively little from China and Mexico. Planning actions to protect margins including taking exemptions under US-Mexico-Canada agreement, US Department of Defense exemptions, and pricing actions as needed.
• Outlook: Assumed 1% negative sales impact offset by Qioptiq acquisition, 2025 estimated sales ~$6 billion. Maintained full year earnings outlook.

Segment Performance

• Digital Imaging: Represents approximately 52% of Teledyne's portfolio. First quarter 2025 sales increased 2.2%. Non-GAAP operating margin improved 31 basis points.
• Instrumentation: Consists of marine, environmental, and test and measurement. First quarter total sales increased 3.9% vs last year with organic growth of 2.6%. Marine instruments sales up 9.5%, environmental instruments down 2%, book-to-bill of 1.11x. Operating margin increased 97 basis points to 27% (GAAP) and 27.9% (non-GAAP).
• Aerospace and Defense Electronics: First quarter organic sales increased 7.8%, including acquisitions, sales up 30.6%. Segment operating profit increased year-over-year, but margins decreased due to transaction and integration costs.
• Engineered Systems: First quarter revenue increased 14.9%, segment operating profit increased 719 basis points due to easy comparison with prior year.

Guidance

• Second quarter 2025: GAAP earnings per share range $4.00 to $4.15, non-GAAP $4.95 to $5.05.
• Full year 2025: GAAP earnings per share range $17.35 to $17.83, non-GAAP $21.10 to $21.50.

Risks

• Tariffs and trade policies impacting margins.
• Potential impact of economic uncertainty on sales, especially in Digital Imaging and Instrumentation segments.
• Exposure to China with ~2% of sales to China, affecting products like oscilloscopes and environmental equipment.

Question and Answer

• Q: Greg Konrad with Jefferies on tariffs, revenue impact, organic growth, FX headwinds. A: Robert Mehrabian on tariff impact, segment effects, China sales.
• Q: Andrew Buscaglia with BNP Paribas on government spending cuts, short-cycle sales. A: Robert Mehrabian on minimal impact, segment growth expectations.
• Q: Jim Ricchiuti with Needham & Company on margin improvement in acquired businesses, acquisition opportunities. A: Robert Mehrabian on margin improvement, acquisition pipeline.
• Q: Jordan Lyonnais with Bank of America on Aerospace and Defense segment, European rearmament. A: Robert Mehrabian on defense sales growth, European manufacturing footprint.
• Q: Damian Karas with UBS on GDP impact, supply chain actions. A: Robert Mehrabian on GDP impact, supply chain actions and pricing.
• Q: Joe Giordano with TD Cowen on backlog, margin profile of NASA work, China sales. A: Robert Mehrabian on backlog, margin impact of NASA work, China sales.
• Q: Guy Hardwick with Freedom Capital Markets on Canadian business, COGS from imports. A: Robert Mehrabian on Canadian business balance, COGS from imports.
• Q: Rob Jamieson with Vertical Research Partners on capital allocation, test and measure end markets. A: Robert Mehrabian on capital allocation, test and measure business details.